Anti-obesity and anti-diabetic effects of mazindol in yellow KK mice: Its activating effect on brown adipose tissue thermogenesis

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 6-7, 1996, Pages 476-482

  Yoshida, Toshihide ^a   Umekawa, Tsunekazu ^a   Wakabayashi, Yasuo ^a   Yoshimoto, Kanji ^a   Sakane, Naoki ^a   Kondo, Motoharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

bodyweight loss; brown adipose tissue; diabetes; food intake; glucose loading test; glucose transporter 4; mazindol; noradrenaline turnover; obesity; thermogenesis

Indexed keywords

MAZINDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIABETES MELLITUS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INTRAGASTRIC DRUG ADMINISTRATION; MOUSE; NONHUMAN; OBESITY; THERMOGENESIS; WEIGHT REDUCTION;

EID: 0029884851     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02764.x     Document Type: Article

References (40)

1. Heikkila RE. Differential effects of several dopamine uptake inhibitors and releasing agents on locomotor activity in normal and in reserpinized mice. Life Sci. 1981; 28: 1868-73.
2. Minami T, Oomura Y, Sugimori M, Hynes M. Direct action of mazindol on guinea-pig ventromedial hypothalamic neurons: Intracellular studies in slice preparation. Brain Res. Bull. 1985; 15: 29-31.
3. Engstrom RG, Kelly LA, Gogerty JH. The effects of 5-hydroxy-5-(4′-chlorophenyl)-2,3-dihydro-5H-imidazo(2,1-a)isoindole (Mazindol, SaH 42-548) on the metabolism of brain norepinephrine. Arch. Int. Pharmacodyn. Ther. 1975; 214: 308-21.
4. Shimizu N, Take S, Hori T, Oomura Y. Hypothalamic microdialysis of mazindol causes anorexia with increase in synaptic serotonin in rats. Physiol. Behav. 1991; 49: 131-4.
5. Rothwell NJ, Stock MJ. A role for brown adipose tissue in diet-induced thermogenesis. Nature 1979; 281: 31-5.
6. Trayhurn P. Brown adipose tissue and energy balance. In: Trayhurn P, Nicholls DG (eds.) Brown Adipose Tissue. Arnold, London. 1986; 299-338.
7. Foster DO. Quantitative role of brown adipose tissue in thermogenesis. In: Trayhurn P, Nicholls DG (eds) Brown Adipose Tissue. Arnold, London. 1986; 31-51.
8. Himms-Hagen J. Brown adipose tissue thermogenesis and obesity. Progr. Lipid Res. 1989; 28: 67-115.
9. Yoshida T. The significant role of brown adipose tissue in the development of obesity. In: Romsos DR, Himms-Hagen J, Suzuki M (eds). Obesity: Dietary Factor and Control. Japan Scientific Societies Press, Tokyo. 1991; 97-106.
10. Perkins MN, Rothwell NJ, Stock MJ, Stone TW. Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus. Nature 1981; 289: 401-2.
11. Saito M, Minokoshi Y, Shimazu T. Brown adipose tissue after ventromedial hypothalamic lesions in rats. Am. J. Physiol. 1985; 248: E20-5.
12. Arch JRS, Ainsworth AT, Cawthorne MA et al. Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 1984; 309: 163-5.
13. 3-adrenoceptor agonist, in yellow KK mice. Life Sci. 1994; 54: 491-8.
14. Iwatsuka H, Shino A, Suzuki Z. General survey of diabetic features of yellow KK mice. Endocrinol. Jpn. 1970; 17: 23-35.
15. Fujita T, Sugiyama T, Taketomi S et al. Reduced insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexyl-methoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63, 287, Ciglitazone), a new antidiabetic agent. Diabetes 1983; 32: 804-10.
16. Cannon B, Lindberg O. Mitochondria from brown adipose tissue: Isolation and properties. Methods Enzymol. 1979; 55: 65-78.
17. Lowry OH, Roserough AL, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol Chem. 1951; 193: 265-75.
18. Yonetani T, Ray GS. Studies on cytochrome oxidase: Kinetics of the aerobic oxidation of ferrocytochrome c by cytochrome oxidase. J. Biol. Chem. 1965; 240: 3392-8.
19. Nicholls DG. Hamster brown adipose tissue mitochondria. Purine nucleotide control of ion conductance of the inner membrane and the nature of nucleotide binding site. Eur. J. Biochem. 1976; 63: 223-8.
20. Young JB, Landsberg L. Stimulation of the sympathetic nervous system during sucrose feeding. Nature 1977; 269: 615-17.
21. Yoshida T, Kemnitz J, Bray GA. Lateral hypothalamic lesions and norepinephrine turnover in rats. J. Clin. Invest. 1983; 72: 919-27.
22. Yoshida T, Nishioka H, Yoshioka K, Kondo M. Reduced norepinephrine turnover in interscapular brown adipose tissue of obese rats after ovariectomy. Metabolism 1987; 36: 1-6.
23. Zar JH. Biostatistical analysis. Prentice-Hall, New Jersey. 1974.
24. Tsukazaki K, Nikami H, Shimizu Y, Kawada T, Yoshida T, Saito M. Chronic administration of β-adrenergic agonists can mimic the stimulative effect of cold exposure on protein synthesis in rat brown adipose tissue. J. Biochem. 1995; 117: 96-100.
25. Shimizu Y, Nikami H, Tsukazaki K et al. Increased expression of glucose transporter GLUT4 in brown adipose tissue of fasted rats after cold exposure. Am. J. Physiol. 1993; 264: E890-5.
26. Wyllie MG, Fletcher A, Rothwell NJ, Stock MJ. Thermogenic properties of ciclazindol and mazindol in rodents. Int. J. Obesity 1984; 8 (Suppl.): 85-92.
27. Lupien JR, Bray GA. Effect of mazindol, d-amphetamine and diethylpropion on purine nucleotide binding to brown adipose tissue. Pharmacol. Biochem. Behav. 1986; 25: 733-8.
28. Shimazu T, Noma M, Saito M. Chronic infusion of norepinephrine into the ventromedial hypothalamus induces obesity in rats. Brain Res. 1986; 369: 215-23.
29. Basile AS, Dunwiddie TV. Norepinephrine elicits both excitatory and inhibitory responses from Purkinje cells in the in vitro rat cerebellar slice. Brain Res. 1984; 296: 15-25.
30. Collins GGS, Probett GA, Anson J, McLaughlin NJ. Excitatory and inhibitory effects of noradrenaline on synaptic transmission in the rat olfactory cortex slice. Brain Res. 1984; 294: 211-23.
31. Yoshida T, Sakane N, Umekawa T, Yoshioka K, Kondo M, Wakabayashi Y. Usefulness of mazindol on combined diet therapy consisting of a low-calorie diet and Optifast in severe obese women. Int. J. Clin. Pharmacol. Res. 1994; 14: 125-32.
32. Shiraishi T. Effects of mazindol on salivary and gastric acid secretions in dogs. Folia Pharmacol. Jpn. 1984; 83: 159-72.
33. Nishioka H, Yoshida T, Yoshioka K, Kondo M. Hyperinsulinemic yellow KK mice and norepinephrine turnover. Endocrinol. Jpn. 1987; 34: 489-95.
34. Vander Tuig JG, Kerner J, Romsos DR. Hypothalamic obesity, brown adipose tissue, and sympathoadrenal activity in rats. Am. J. Physiol. 1985; 248: E607-17.
35. Yoshida T, Nishioka H, Nakamura Y, Kanatsuna T, Kondo M. Reduced norepinephrine turnover in brown adipose tissue of preobese mince treated with monosodium-L-glutamate. Life Sci. 1985; 36: 931-8.
36. Nagai K, Nagai N, Isojima Y, Itoh S, Okumura N, Nakagawa H. Mazindol enhances glucose uptake by rat skeletal muscle. Eur. J. Pharmacol 1994; 260: 29-37.
37. Machado UF, Shimizu I, Saito M. Decreased glucose transporter (GLUT4) content in insulin-sensitive tissues of obese aurothioglucose- and monosodium glutamate-treated mice. Hormone Metab. Res. 1993; 25: 462-65.
38. Koranyi L, James D, Mueckler M, Permutt MA. Glucose transporter levels in spontaneously obese (db/db) insulin-resistant mice. J. Clin. Invest. 1990; 85: 962-7.
39. Le Marchand-Brustel Y, Olichon-Beerthe C, Gremeaux T, Tanti J-F, Rochet N, Van Obberghen E. Glucose transporter in insulin sensitive tissues of lean and obese mice. Effect of the thermogenic agent BRL26830A. Endocrinology 1990; 27: 2687-95.
40. Hainault I, Guerre-Milo M, Guichard C, Lavau M. Differential regulation of adipose tissue glucose transporters in genetic obesity (fatty rat). J. Clin. Invest. 1991; 87: 1127-31.